--- title: "2 只勢不可擋的股息股票，現可購買，價格低於 1000 美元" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/278268870.md" description: "碧迪醫療（Becton, Dickinson，NYSE: BDX）和美敦力（Medtronic，NYSE: MDT）被認為是千元以下的頂級分紅股票。碧迪醫療擁有 50 年的分紅增長曆史，收益率為 2.4%；而美敦力接近分紅王的地位，提供 2.9% 的收益率，並且其新型手術機器人具有增長潛力。儘管面臨近期挑戰，這兩家公司仍然具備增長潛力，成為希望增強醫療保健投資組合的分紅投資者的吸引選項" datetime: "2026-03-08T13:40:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278268870.md) - [en](https://longbridge.com/en/news/278268870.md) - [zh-HK](https://longbridge.com/zh-HK/news/278268870.md) --- # 2 只勢不可擋的股息股票，現可購買，價格低於 1000 美元 ## Key Points - Dividend King Becton, Dickinson has an incredible dividend history and an attractive yield. - Medtronic's dividend history is impressive, but the real draw is the growth potential of its new surgical robot. - 10 stocks we like better than Becton › Most investors don't associate the healthcare sector with dividends, but there are some pretty impressive dividend stocks to be had. Two that stand out today are **Becton, Dickinson** (NYSE: BDX) and **Medtronic** (NYSE: MDT). Here's why these unstoppable dividend stocks could find a home in your portfolio today. ## Becton, Dickinson is a Dividend King The big dividend story with Becton, Dickinson is that it has increased its dividend annually for more than 50 years, placing it on the highly elite list of Dividend Kings. Becton, Dickinson isn't really a headline player, like **Eli Lilly** is with its dominant GLP-1 drugs. Becton, Dickinson is more of a "pick-and-shovel" play, with a large medical-surgical business (basics like syringes) and medical device operations, among other things. _**Will AI create the world's first trillionaire?** Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »_ ![A surgical robot.](https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg1NzE2MC8yNV8xMl8yOS1hLXN1cmdpY2FsLXJvYm90LV9yb2JvdGljLXN1cmdlcnktc3VyZ2ljYWwtZXF1aXBtZW50LTEwNjd4ODAwLTlmOGExNTcuanBnJnc9NzAw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) Image source: Getty Images. The company hasn't been executing well of late, but it has a pipeline of new products that should help to get the company moving in the right direction again. And it just completed the spinoff of a division that didn't fit well with the rest of its business. That should allow management to focus more keenly on returning to growth. Add in a well-above-market 2.4% yield, and dividend investors who think in decades may want to consider jumping aboard while Wall Street is still downbeat on the stock. ## Medtronic is setting itself up for growth Medical device peer Medtronic is just a couple of years shy of Dividend King status. So its dividend bona fides are very strong as well. The stock's dividend yield is an even more attractive 2.9%. Like Becton, Dickinson, Medtronic has been working through a weak patch. However, that could be on the verge of changing. Medtronic has just begun selling surgical robots in the U.S. market. It is a potentially large growth opportunity, noting surgical robotics leader **Intuitive Surgical** has been afforded a P/E ratio of 63x because of its strong growth. Medtronic's P/E is a far more modest 27x. While it has a more diverse business, it seems reasonable to expect the market to reward Medtronic with a higher valuation based on its surgical robotics advances. ## Two reliable dividend stocks If you have $1,000 or even less, you'll be able to buy Becton, Dickinson and Medtronic. In fact, $1K will let you buy five shares of Dividend King Becton, Dickinson, or 10 shares of aspiring Dividend King Medtronic. Either one could be a solid healthcare stock for your dividend portfolio, but don't wait too long, as both now have catalysts that may spur higher valuations. ## Should you buy stock in Becton right now? Before you buy stock in Becton, consider this: The _Motley Fool Stock Advisor_ analyst team just identified what they believe are the **10 best stocks** for investors to buy now… and Becton wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when **Netflix** made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, **you’d have $534,008**!\* Or when **Nvidia** made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, **you’d have $1,090,073**!\* Now, it’s worth noting _Stock Advisor’s_ total average return is 949% — a market-crushing outperformance compared to 190% for the S&P 500. **Don't miss the latest top 10 list, available with _Stock Advisor_, and join an investing community built by individual investors for individual investors.** See the 10 stocks » _\*Stock Advisor returns as of March 8, 2026._ _Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends Medtronic and recommends the following options: long January 2028 $520 calls on Intuitive Surgical and short January 2028 $530 calls on Intuitive Surgical. The Motley Fool has a disclosure policy._ The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. ### 相關股票 - [XHE.US](https://longbridge.com/zh-HK/quote/XHE.US.md) - [MDT.US](https://longbridge.com/zh-HK/quote/MDT.US.md) - [BDX.US](https://longbridge.com/zh-HK/quote/BDX.US.md) - [IHI.US](https://longbridge.com/zh-HK/quote/IHI.US.md) ## 相關資訊與研究 - [鉅亨速報 - Factset 最新調查：美敦力公司 (MDT-US) EPS 預估下修至 5.52 元，預估目標價為 111.00 元](https://longbridge.com/zh-HK/news/282861471.md) - [美敦力 CEO 傑夫·馬薩：中國正在成為全球醫療科技創新的重要策源地](https://longbridge.com/zh-HK/news/281590837.md) - [安達人壽推「永富長紅」分紅保單 提供雙重紅利、強化壽險保障](https://longbridge.com/zh-HK/news/282789168.md) - [法國巴黎人壽揭今年 3 商品主軸 擬推新分紅保單](https://longbridge.com/zh-HK/news/282711835.md) - [富衞指首季維持增長勢頭 擬為團體醫療保險添保障](https://longbridge.com/zh-HK/news/282811647.md)